Penserra Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.86 - $13.95 $40,453 - $51,963	-3,725 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $476 - $556	40 Added 1.09%	3,725 $48,000
Q2 2021 Aug 12, 2021	BUY	$10.16 - $13.11 $355 - $458	35 Added 0.96%	3,685 $47,000
Q1 2021 May 13, 2021	SELL	$9.04 - $11.86 $723 - $948	-80 Reduced 2.14%	3,650 $40,000
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $21,394 - $28,840	2,364 Added 173.06%	3,730 $42,000
Q3 2020 Nov 13, 2020	BUY	$8.99 - $10.74 $12,280 - $14,670	1,366 New	1,366 $12,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $530M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.